Recombinant multi-species KDM1/KDM1A/LSD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KDM1/KDM1A/LSD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a nuclear protein containing a SWIRM domain, a FAD-binding motif, and an amine oxidase domain. This protein is a component of several histone deacetylase complexes, though it silences genes by functioning as a histone demethylase. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
The Alternative Names of target: 1810043O07Rik,AIMAH3,AOF2,Aof2,BHC110,BRAF35-HDAC complex protein BHC110,CPRF,D4Ertd478e,Flavin-containing amine oxidase domain-containing protein 2,KDM1,KDM1A,Kdm1,Kdm1a,LSD,LSD1,Lsd1,Lysine-specific histone demethylase 1A,RGD1562975,[histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A,mKIAA0601

Target products collectionGo to KDM1/KDM1A/LSD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T16739-Ag-1/ GM-Tg-hg-T16739-Ag-2 Human KDM1/KDM1A/LSD protein Human
GM-Tg-rg-T16739-Ag-1/ GM-Tg-rg-T16739-Ag-2 Rat KDM1/KDM1A/LSD protein Rat
GM-Tg-mg-T16739-Ag-1/ GM-Tg-mg-T16739-Ag-2 Mouse KDM1/KDM1A/LSD protein Mouse
GM-Tg-cynog-T16739-Ag-1/ GM-Tg-cynog-T16739-Ag-2 Cynomolgus/Rhesus macaque KDM1/KDM1A/LSD protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T16739-Ag-1/ GM-Tg-felg-T16739-Ag-2 Feline KDM1/KDM1A/LSD protein Feline
GM-Tg-cang-T16739-Ag-1/ GM-Tg-cang-T16739-Ag-2 Canine KDM1/KDM1A/LSD protein Canine
GM-Tg-bovg-T16739-Ag-1/ GM-Tg-bovg-T16739-Ag-2 Bovine KDM1/KDM1A/LSD protein Bovine
GM-Tg-equg-T16739-Ag-1/ GM-Tg-equg-T16739-Ag-2 Equine KDM1/KDM1A/LSD protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T16739-Ag-1/ GM-Tg-hg-T16739-Ag-2; GM-Tg-rg-T16739-Ag-1/ GM-Tg-rg-T16739-Ag-2;
GM-Tg-mg-T16739-Ag-1/ GM-Tg-mg-T16739-Ag-2; GM-Tg-cynog-T16739-Ag-1/ GM-Tg-cynog-T16739-Ag-2;
GM-Tg-felg-T16739-Ag-1/ GM-Tg-felg-T16739-Ag-2; GM-Tg-cang-T16739-Ag-1/ GM-Tg-cang-T16739-Ag-2;
GM-Tg-bovg-T16739-Ag-1/ GM-Tg-bovg-T16739-Ag-2; GM-Tg-equg-T16739-Ag-1/ GM-Tg-equg-T16739-Ag-2
Products Name KDM1/KDM1A/LSD protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name KDM1/KDM1A/LSD
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KDM1/KDM1A/LSD protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.